Since then, genome-wide studies have inferred potential regulatory cooperativity between AP1 and other ETS factors such as ELK1 [31] and ERG [18] and in the latter case this association is thought to be important for the context of prostate cancer. This evidence concerns the gene ELK1 and prostate carcinoma.